We provide fractional CXO expertise specifically for FemTech companies navigating regulatory complexity, trust-building challenges, and sustainable scaling.

The Problem

Traditional executives don't understand FemTech-specific regulatory and cultural challenges

Generic C-level hires bring SaaS or healthcare experience but lack the nuanced understanding of women's health market dynamics. They underestimate platform advertising restrictions, cultural taboos around reproductive health, and the complex trust-building requirements for intimate health products. Your executive team makes strategic decisions based on traditional growth playbooks that fail in FemTech contexts. Meanwhile, competitors with specialized leadership gain ground while your team learns painful lessons through trial and error.

Fundraising timelines don't align with executive hiring and onboarding needs

Investors expect senior leadership in place, but you can't afford C-level salaries until after closing funding rounds. The chicken-and-egg problem leaves you with junior leadership during critical growth phases. By the time you can hire senior executives, you've made strategic mistakes that cost months of progress. Full-time executive searches take 3-6 months, but FemTech companies need strategic leadership immediately to navigate regulatory and market challenges.

Women's health expertise doesn't scale across all business functions

Your founding team understands the medical and user experience aspects of women's health but lacks expertise in scaling operations, building regulatory-compliant marketing systems, or managing cross-cultural product rollouts. You need senior leadership that combines FemTech domain knowledge with scaling experience. Internal promotions create skill gaps while external hires need months to understand your market nuances.

Board and investor expectations clash with FemTech market realities

Your board expects traditional SaaS metrics and growth rates, but women's health markets have different adoption curves and trust-building timelines. You need executive leadership that can communicate FemTech-appropriate success metrics to investors while optimizing for sustainable growth. Junior leadership can't bridge this gap between investor expectations and market realities, creating friction in board meetings and fundraising processes.

How We Help

Our fractional CXO service provides immediate access to senior leadership with deep FemTech expertise. We've scaled women's health companies through regulatory hurdles, platform restrictions, and cultural challenges that generic executives haven't encountered. Our fractional model gives you C-level strategic thinking and execution without the $300K+ salary commitment. We integrate directly with your team and board, providing the senior voice you need in critical business decisions.

Our approach starts with rapid FemTech market assessment and strategy alignment. In the first 30 days, we audit your current business model against FemTech best practices, identify regulatory and cultural risks, and align your strategy with women's health market realities. We work directly with your founding team to transfer FemTech scaling knowledge while making immediate strategic improvements. This includes board communication, investor relations, and strategic hiring priorities.

Then we tackle the specific operational challenges that derail FemTech companies. This includes building regulatory-compliant marketing and sales processes, creating trust-building customer acquisition systems, and establishing women's health-appropriate success metrics. We work across all business functions—marketing, product, operations, and finance—to implement FemTech-specific best practices. Our goal is sustainable scaling that works within the constraints and opportunities of women's health markets.

Our execution model embeds senior leadership into your daily operations without the overhead of full-time executives. We participate in board meetings, investor updates, strategic planning sessions, and cross-functional leadership meetings. We provide direct mentorship to your leadership team while making hands-on contributions to critical initiatives. This includes fundraising support, strategic partnership development, and regulatory compliance oversight.

Finally, we establish processes and systems that prepare your company for eventual full-time senior leadership hires. We document FemTech-specific strategies, build institutional knowledge, and establish success metrics that work for women's health businesses. Our engagement creates a foundation for sustainable growth while preparing your company to attract and onboard senior executives who understand FemTech market dynamics.

What we deliver

Immediate senior leadership with FemTech scaling expertise and regulatory knowledge
Strategic business model optimization for women's health market realities and investor expectations
Regulatory-compliant operational systems for marketing, sales, and customer acquisition
Board and investor communication strategy with FemTech-appropriate success metrics
Leadership team development and preparation for eventual full-time executive hiring

FemTech companies fail when they apply traditional SaaS scaling strategies to women's health markets. Successful scaling requires senior leadership that understands both business growth and the unique regulatory, cultural, and trust-building challenges of reproductive health.

Our Methodology

Our fractional CXO methodology provides immediate strategic impact through a FemTech-focused leadership framework. Month one includes rapid business assessment, regulatory risk audit, and board/investor alignment on FemTech-appropriate metrics. Month two implements operational improvements and strategic initiatives specific to women's health market challenges. Month three establishes sustainable scaling processes and prepares for leadership transition or extension. Unlike traditional executive consulting, we integrate as active leadership team members, participating in daily operations and strategic decisions. This hands-on approach delivers immediate value while building long-term strategic capability.

How We Work

Fractional CXO engagements begin with 1 week of intensive business and market assessment focused on FemTech-specific challenges and opportunities. We review your current strategy, regulatory compliance status, and growth metrics against women's health industry benchmarks. We conduct stakeholder interviews with your team, board members, and key investors to understand expectations and alignment gaps. This assessment requires full access to business operations and strategic documentation.

Days 7-60 focus on immediate strategic implementation and operational optimization. We participate in weekly leadership meetings, board calls, and strategic planning sessions as an integrated team member. We work directly with your marketing, product, and operations teams to implement FemTech best practices. We provide direct support for fundraising, partnership development, and regulatory compliance initiatives. This phase requires 15-20 hours per week of engagement across strategic and operational activities.

Days 60-90 emphasize sustainable scaling and leadership development. We establish ongoing processes for FemTech-appropriate measurement and reporting. We provide mentorship to your internal leadership team and support strategic hiring decisions. We document institutional knowledge and strategic frameworks for continued growth. Most engagements extend quarterly as companies scale, with the option to transition to advisory role as full-time executive team develops.

Strategic business optimization with FemTech expertise and regulatory compliance
Immediate senior leadership impact without full-time executive salary commitment

If your femtech company needs fractional cxo leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

How much does a fractional CXO engagement cost for FemTech companies?

Fractional CXO engagements for FemTech companies typically range from $15,000 to $35,000 monthly, depending on involvement level and company complexity. This represents 40-60% savings compared to full-time senior executive compensation while providing immediate access to FemTech expertise. The investment includes strategic planning, operational optimization, board participation, and leadership team development. Most clients see strategic impact within the first 30 days and operational improvements within 60-90 days.

How long before we see results from fractional CXO leadership?

Strategic clarity and board alignment improvements appear within the first 2-3 weeks of engagement. Operational optimization and process improvements typically show results at the 30-45 day mark. Meaningful business growth and scaling improvements become evident at 60-90 days as FemTech-specific strategies take effect. Full strategic transformation takes 4-6 months because cultural and regulatory changes in women's health require sustained leadership focus.

How does a fractional CXO integrate with our existing leadership team?

We integrate as active members of your leadership team, participating in all strategic meetings, board calls, and major business decisions. Integration requires weekly one-on-one sessions with key team members and monthly strategic planning facilitation. We provide direct mentorship to existing leaders while making hands-on contributions to critical initiatives. Expect 15-20 hours per week of direct engagement during active phases, with flexibility for urgent strategic needs.

What makes Winston Francois different from traditional fractional CXO services?

Traditional fractional executives apply generic business strategies without understanding FemTech market dynamics, regulatory constraints, or cultural challenges specific to women's health. We bring deep expertise in scaling FemTech companies through platform restrictions, regulatory compliance, and trust-building challenges that generic executives haven't encountered. Our approach combines senior business leadership with specialized women's health market knowledge.

How do you measure ROI from fractional CXO engagements?

We measure success through FemTech-appropriate metrics including regulatory compliance improvements, trust-building effectiveness, sustainable growth rate optimization, and board/investor satisfaction with strategic progress. Traditional metrics like revenue growth are tracked but contextualized for women's health market realities. ROI measurement includes both immediate strategic impact and long-term business value creation through improved scaling capability and market positioning.

What type of FemTech company is the right fit for fractional CXO services?

We work best with Series A to growth-stage FemTech companies ($1M-$25M ARR) that have product-market fit but need senior leadership for scaling challenges. Ideal clients face regulatory compliance needs, platform advertising restrictions, or board/investor alignment issues around growth expectations. Companies preparing for fundraising or major market expansion benefit most from fractional CXO expertise. The first step is a strategic assessment to identify immediate leadership needs and growth opportunities.